Optimizing outcome reporting after radical cystectomy for organ-confined urothelial carcinoma of the bladder using oncological trifecta and pentafecta

[1]  K. Guru,et al.  Systematic review and cumulative analysis of perioperative outcomes and complications after robot-assisted radical cystectomy. , 2015, European urology.

[2]  B. Hadaschik,et al.  Evidence from the ‘PROspective MulticEnTer RadIcal Cystectomy Series 2011 (PROMETRICS 2011)’ Study: How are Preoperative Patient Characteristics Associated with Urinary Diversion Type After Radical Cystectomy for Bladder Cancer? , 2015, Annals of Surgical Oncology.

[3]  G. Bartsch,et al.  Risk stratification for locoregional recurrence after radical cystectomy for urothelial carcinoma of the bladder , 2015, World Journal of Urology.

[4]  T. Todenhöfer,et al.  Fluorescence-guided bladder tumour resection: impact on survival after radical cystectomy , 2015, World Journal of Urology.

[5]  F. Montorsi,et al.  Fifteen-year single-centre experience with three different surgical procedures of nerve-sparing cystectomy in selected organ-confined bladder cancer patients , 2015, World Journal of Urology.

[6]  M. Wirth,et al.  External validation of a model to predict locoregional failure after radical cystectomy , 2014, Cancer.

[7]  C. Stief,et al.  Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohort. , 2014, European urology.

[8]  C. Tangen,et al.  Optimizing bladder cancer locoregional failure risk stratification after radical cystectomy using SWOG 8710 , 2014, Cancer.

[9]  J. Witjes,et al.  EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines. , 2014, European urology.

[10]  N. Shinohara,et al.  1615 PERIOPERATIVE MORBIDITY AND MORTALITY RELATED TO RADICAL CYSTECTOMY: A MULTI-INSTITUTIONAL RETROSPECTIVE STUDY IN JAPAN , 2013 .

[11]  N. Shinohara,et al.  Peri‐operative morbidity and mortality related to radical cystectomy: a multi‐institutional retrospective study in Japan , 2012, BJU international.

[12]  W. Otto,et al.  Predictive capacity of four comorbidity indices estimating perioperative mortality after radical cystectomy for urothelial carcinoma of the bladder , 2012, BJU international.

[13]  T. Kälble,et al.  Serosa‐lined and tapered ileum as primary and secondary continence mechanism for various catheterizable pouches , 2012, BJU international.

[14]  P. Mulders,et al.  Use of neoadjuvant chemotherapy for muscle-invasive bladder cancer is low among major European centres: results of a feasibility questionnaire. , 2012, European urology.

[15]  Y. Lotan,et al.  Death certificates are valid for the determination of cause of death in patients with upper and lower tract urothelial carcinoma. , 2012, European urology.

[16]  F. Burkhard,et al.  Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study. , 2011, The Journal of urology.

[17]  K. Palmer,et al.  Pentafecta: a new concept for reporting outcomes of robot-assisted laparoscopic radical prostatectomy. , 2011, European urology.

[18]  C. Stief,et al.  Association Between the Number of Dissected Lymph Nodes During Pelvic Lymphadenectomy and Cancer-Specific Survival in Patients with Lymph Node–Negative Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy , 2011, Annals of Surgical Oncology.

[19]  D. Wood,et al.  Body image and bladder cancer specific quality of life in patients with ileal conduit and neobladder urinary diversions. , 2010, Urology.

[20]  C. Dinney,et al.  Risk factor analysis in a contemporary cystectomy cohort using standardized reporting methodology and adverse event criteria. , 2010, The Journal of urology.

[21]  U. Studer,et al.  A new multimodality technique accurately maps the primary lymphatic landing sites of the bladder. , 2010, European urology.

[22]  B. Davies,et al.  Estimating postoperative mortality and morbidity risk of radical cystectomy with continent diversion using predictor equations. , 2009, The Journal of urology.

[23]  Michael McCormack,et al.  A population based assessment of perioperative mortality after cystectomy for bladder cancer. , 2009, The Journal of urology.

[24]  J. Gore,et al.  Mortality increases when radical cystectomy is delayed more than 12 weeks , 2009, Cancer.

[25]  M. Wirth,et al.  Perioperative complications of radical cystectomy in a contemporary series. , 2007, European urology.

[26]  Yair Lotan,et al.  Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. , 2006, The Journal of urology.

[27]  P. Scardino,et al.  Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function ("trifecta"). , 2005, Urology.

[28]  J. Thüroff,et al.  Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis , 2000, BJU international.

[29]  Jie Cai,et al.  "Trifecta" in partial nephrectomy. , 2013, The Journal of urology.

[30]  B. Bochner,et al.  Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. , 2009, European urology.

[31]  L. Sobin,et al.  TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.